(1 - 23 from 23
)
Exelixis Announces Phase 1 Trial Results for Cabozantinib in ...ir.exelixis.com › news-releases › news-release-details › exelixis-annou...
ir.exelixis.com
... new options,” said Andrea Apolo , M.D., Genitourinary Malignancies Branch, Center for Cancer Research , National Cancer Institute , the principal investigator ...
NIH Announces Lasker Clinical Research Scholars | News ...philanthropynewsdigest.org › news › nih-announces-lasker-clinical-re...
philanthropynewsdigest.org
... and Blood Institute; Andrea Apolo, chief of the bladder cancer section at the National Cancer Institute; and Falk Lohoff, chief of the section on ...
Press Release - Investor - Exelixis
ir.exelixis.com
Dr. Andrea Apolo , Center for Cancer Research , National Cancer Institute , Bethesda, MD Oral Abstract Session: Genitourinary Cancer Monday ...
Reminder: Cabozantinib to be Featured in Nine Presentations at the...
ir.exelixis.com
Dr. Andrea Apolo , Center for Cancer Research , National Cancer Institute , Bethesda, MD General Poster Session: Genitourinary (Nonprostate) Cancer (Trials in ...
sorted by relevance / date